All lobbying filings

THE INGRAM GROUP LLC

Lobbying for LYNCH REGENERATIVE MEDICINE, LLC · biotech company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Tennessee

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Medicare/Medicaid

Issues related to Local Coverage Determinations (LCDs) implementation. Issues related to the Finalized CY 2026 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.